{"disease":{"id":"thrombocytopaenia","name":"thrombocytopaenia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02158936","title":"A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":356,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT07278661","title":"Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery.","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":136,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT06761131","title":"Compare Linezolid-Induced Thrombocytopenia in Patients With Normal Renal Function Versus Impaired Renal Function","phase":"","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT01657552","title":"Eltrombopag/Boceprevir and Eltrombopag/Telaprevir Drug-Drug Interaction Study In Healthy Adult Subjects","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"GlaxoSmithKline","has_results":false},{"nct_id":"NCT01957176","title":"A Rollover Study to Provide Continued Treatment With Eltrombopag","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":22,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT00358540","title":"Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"GlaxoSmithKline","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}